Cost analysis of bivalirudin versus reference anticoagulants without GP IIb/IIIa inhibitors in patients undergoing percutaneous coronary intervention for acute coronary syndrome in routine clinical practice. Pompidou registry-Reference-Cited by-同舟云学术

Cost analysis of bivalirudin versus reference anticoagulants without GP IIb/IIIa inhibitors in patients undergoing percutaneous coronary intervention for acute coronary syndrome in routine clinical practice. Pompidou registry

Published:2013-04 Issue:2 Volume:62 Page:89-94
ISSN:0003-3928
Container-title:Annales de Cardiologie et d'Angéiologie
language:en
Short-container-title:Annales de Cardiologie et d'Angéiologie

Author:

Puymirat E.,Cohen S.,Védrenne G.,Caruba T.,Sabatier B.,Danchin N.,Durand E.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference18 articles.

1. Bivalirudin for patients with acute coronary syndromes;Stone;N Engl J Med,2006

2. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoproteinIIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial;Lincoff;JAMA,2003

3. Bivalirudin versus unfractionated heparin during percutaneous coronary intervention;Kastrati;N Engl J Med,2008

4. Bivalirudin during primary PCI in acute myocardial infarction;Stone;N Engl J Med,2008

5. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC);Steg;Eur Heart J,2012

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A meta‐analysis and cost‐minimization analysis of bivalirudin versus heparin in high‐risk patients for percutaneous coronary intervention;Pharmacology Research & Perspectives;2021-05

2. Evaluation on the efficacy and safety of domestic bivalirudin during percutaneous coronary intervention;Chinese Medical Journal;2013-08-30